While Microsoft generally keeps its patent licensing agreements tightly under wraps, China’s Ministry of Commerce offered a glimpse into the money the tech giant makes from those deals, particularly with rival Google.
MOFCOM reportedly published details of Microsoft’s licensing deals made with Google for Android smartphone devices, reporting 73 standard-essential patents that were reviewed by regulators. The information was published on its site in part of its review of Microsoft’s proposed acquisition of Nokia’s handset operations, a $7.2 billion deal that concerned Chinese authorities over how it would affect Microsoft’s patent licensing agreements. Reports say MOFCOM examined the deal to determine whether the patents acquired through the Nokia purchase would encourage the companies to hike licensing fees.
MOFCOM approved of the merger last April.
In addition to the SEPs, MOFCOM reported 127 patents implemented in Android products that were developed by Microsoft. Reports say Microsoft acquired those patents through its involvement in the Rockstar Consortium, which also includes Apple, BlackBerry, Ericsson and Sony, formed to negotiate licensing deals.
Reports did not indicate the financial details of Microsoft’s licensing deals, but analysts late last year calculated the company was earning up to $2 billion through those agreements.
Full content: ZDNet
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas